Table Of Content

AUTHOR INDEX JANUARY 1, 1995 THROUGH JUNE 15, 1995 Abbo KM, 778 Ballerini L, 637 Boulet AP, 555 Cassagnes J, 330 Collins P, 400 Abbott RD, 166 Balzereit A, 204 Bourke JP, 431 Cassel D, 759, 963 Collins TJ, 853 Abergel E, 425, 498 Baptista J, 287 Bove EL, 370, 408 Castellanos A, 739, 947 Colonna G, 683 Abrams J, 716 Bar FW, 1206 Boveda J, 335, 850 Cave V, 963 Coltart DJ, 1120 Acker M, 754 Barbiere CC, 237 Boxer M, 157 Cazzuola F, 630 Conant RD, 934 Addonizio L, 968 Barbour DJ, 526 Brackett JC, 460 Cecchin F, 71 Concha M, 648 Adler SW, 476 Baron JA, 971 Bramucci E, 675 Celestin C, 1184 Connelly CM, 291 Aepfelbacher FC, 743 Baroni M, 282 Braunwald E, 232, 621, Centamore G, 436 Conti JB, 952 Aguirre FV, 111, 559 Bartakova H, 146 977 Cercek B, 232 Contrada RJ, 503 Ahmed M, 1135 Bashore TM, 58, 485 Bredie SJH, 348 Cerino M, 535 Coppola A, 436 Ahn C, 182, 514, 837 Bassand JP, 330 Breikss A, 767 Chaitman BR, 865, 977 Corbett JR, 720 Airaksinen KEJ, 877 Bateman TM, 718 Bremner S, 516 Chakko S, 184 Cornel JH, 287, 505, 1112 Akasaka T, 639 Bates ER, 1015 Brezden OS, 1088 Chakraborty B, 23 Corretti MC, 783 Akhtar M, 251, 516 Bauman JL, 1184 Brickner ME, 191 Chan CNS, 23 Costagliola D, 425 Alaupovic P, 1124 Beekman RH, 370, 642 Brignole M, 518 Chan WM, 189 Costante AM, 675 Alboni P, 91 Belardinelli L, 952 Brinker JA, 1170 Chang M-H, 317 Counihan PJ, 1056 Alejos JC, 1048, 1294 Belgrave G, 1120 Brouwer J, 796 Chang M-S, 186, 1239 Cowan J, 174 Alexander M, 555 Belhassen B, 316, 511 Brown EJ Jr., 596, 1184 Chapman FW, 1135 Cowell RPW, 415 Algom M, 1272 Beller GA, 228, 653 Brown LE, 621 Chapman J, 511 Cragg D, 573 Allen JK, 1092 Ben-Zur U, 1229 Browne KF, 987 Chapman PD, 1135 Crake T, 725 Allen JW, 960 Bender AM, 971 Brugada P, 698 Chatellier G, 498 Craven TE, 455 Allison DB, 956 Benditt DG, 476 Brundage BH, 1088 Chauvel C, 425 Crea F, 224, 683 Almange C, 411 Benedict C, 354 Buis B, 845 Cheirif J, 982 Cross DB, 172 Almon L, 738 Benedict CR, 1151 Buja G, 1038 Chelliah N, 987 Crouse JR Ill, 455 Amery A, 53 Benson Jr DW, 405 Bultas J, 1102 Chelton S, 503 Crow RS, 1233 Amir G, 511 Berder V, 411 Burgan R, 736 Chen C-H, 1239 Crowley JJ, 633 Ammar A, 465 Berger M, 753 Burger AJ, 305 Chen C-Y, 186 Csanadi Z, 626 Amsterdam EA, 85 Bergillos F, 378 Burger L, 840 Chen S-A, 186 Cucchini F, 204 Anagnostopoulos C, 529 Berti S, 630 Burkhart GA, 213 Cheng C-C, 186 Curtis AB, 952 Anders RJ, 1102 Beyar R, 285 Burnett RE, 1019 Chern M-S, 302 Cutler NR, 1102 Anderson JW, 1196 Beyer J, 645 Burns TL, 754 Cherrier F, 330 Czeizel AE, 1187 Anderson K, 559 Bhadha K, 963 Burrows L, 210 Chevrolet J-C, 842 Anderson ST, 617 Biagini A, 282, 630 Burt R, 568 Chew PH, 596 d’Avila A, 698 Angoli L, 675 Bianchi R, 630 Burton E, 1012 Chiang BN, 186 D’Cruz IA, 308 Anguita M, 378 Bigger JT Jr., 1145 Burton JR, 936 Chiang C-E, 186 Dagenais GR, 1189, 1224 Annoura M, 93 Bigras J-L, 101 Burton Kd, 157 Chikamori T, 508 Daikoku S, 577 Antman EM, 391 Bilianou HI, 293 Butcher RJ, 390 Chin AJ, 61 Dalery K, 1107 Appleton CP, 191 Binder M, 913 Byington RP, 455 Chiou C-W, 186 Daliento L, 1038 Arakawa K, 93 Bisson G, 535 Byrd D, 778 Chiriatti GP, 810 Dallapiccola B, 95 Aranki SF, 553 Bittar N, 1184 Chisholm RJ, 1070 Damaraju S, 1181 Arbab AS, 324 Blackburn H, 316, 1096 Califf RM, 559, 871,1019 Cho SK, 88 Danchin N, 330 Arbustini E, 675 Blanck Z, 251, 516 Callans DJ, 297, 1140 Choi BW, 526 Danford DA, 587 Arizon JM, 648 Blanco J, 648 Calvin JE, 1003 Cholesterol Treatment Daniel WC, 199 Armstrong PW, 1007 Blank R, 956 Camarano G, 215 Trialists’ Collaboration, Danzi G, 675 Armstrong WF, 707, 982 Block PC, 601, 1170 Cambillau M, 127 1130 Danzi GB, 855 Arnese M, 287 Bloom MF, 1116 Cambou J-P, 1202 Chomka EV, 374, 973 Daoud E, 255, 628 Arnold JMO, 621 Bloomfield DM, 1145 Camenzind E, 772 Chou P, 1239 Daubert C, 411 Aronow WS, 182, 302, Blumenthal JA, 1019 Cameron T, 665 Chouraqui P, 321 Davidson MH, 34 514, 837, 1273 Blumenthal M, 596 Camm Ad, 1023 Christian TF, 718 Davies GJ, 725 Ashcom TL, 482 Blumenthal RS, 1092 Campolo L, 675 Chua S, 302 Davignon A, 101 Atakr Multicenter Investi- Boden WE, 1120 Canby RC, 548 Chuang YC, 1267 Davignon J, 1107 gators Group, 50 Boersma E, 287 Cannistra LB, 890 Chung HK, 189 Davis BR, 621 Atger V, 127 Bohlender J, 498 Cannon CP, 232, 977 Chung J, 1229 Davis E, 1244 Atkins DL, 544 Bom H-S, 535 Cannon RO ill, 40, 264, Chung MK, 18 Davis KB, 220 AVID Investigators, 470 Bond MG, 455 443, 1274 Cianflone D, 224 Davis V, 232, 615 Avula SB, 1003 Bondestam E, 767 Cantin B, 1189, 1224 Ciavatti M, 505 Day RW, 196 Awan NA, 1102 Boni E, 1042 Cantwell JD, 1081 Cipriani M, 855 de Bruin TWA, 348 Bonow RO, 526 Capone R, 1244 Ciudad M, 378 De Chiara F, 855 Babcock K, 237 Boomsma F, 796 Caputo GR, 365 Clarkson PBM, 206 de Feyter PJ, 287, 772 Bach DS, 982 Borer JS, 523 Caracciolo EA, 111 Clegg L, 237 de Freitas C, 744 Bach RG, 111 Bornemeier RA, 61 Cardello FP, 45 Clerico A, 630 de Jaegere P, 772 Bacharach SL, 526 Borzak S, 1211 CARE Investigators, 621 Cody RJ, 822 de la Hera A, 947 Badar DM, 264 Boscarini M, 675 Carini G, 535 Coghlan JG, 415 De Pasquale M, 280 Baggett JC, 98 Bosi G, 1277 Carpenter B, 237 Cohen A, 425 De Place C, 411 Baik SH, 88 Bosner MS, 18, 157 Carter S, 141 Cohen JD, 831 de Roos A, 845 Baird M, 555 Bossi IM, 308 Cartwright D, 101 Cohen-Solal A, 998 De Servi S, 675 Bajaj AK, 908 Bot H, 1270 Casazza GA, 85 Cohn CD, 840 Deal B, 587 Bakalyar D, 993 Botti G, 810 Case C, 587 Cohn PF, 840 Deal BJ, 405 Bakr 0, 628 Bottoni N, 518 Casino PR, 40 Cokkinos DV, 293 Decker PJ, 104 Balady GJ, 890 Bouher NJ, 971 Caso R, 335, 850 Colleran JA, 312 deFilippi CR, 191 Balasingam S, 563 Bouilliec M, 842 Caspi A, 763 Collins D, 1196 Dehmer GJ, 170 1296 THE AMERICAN JOURNAL OF CARDIOLOGY® VOL. 75 JUNE 15, 1995 AUTHOR INDEX JANUARY 1, 1995 THROUGH JUNE 15, 1995 Abbo KM, 778 Ballerini L, 637 Boulet AP, 555 Cassagnes J, 330 Collins P, 400 Abbott RD, 166 Balzereit A, 204 Bourke JP, 431 Cassel D, 759, 963 Collins TJ, 853 Abergel E, 425, 498 Baptista J, 287 Bove EL, 370, 408 Castellanos A, 739, 947 Colonna G, 683 Abrams J, 716 Bar FW, 1206 Boveda J, 335, 850 Cave V, 963 Coltart DJ, 1120 Acker M, 754 Barbiere CC, 237 Boxer M, 157 Cazzuola F, 630 Conant RD, 934 Addonizio L, 968 Barbour DJ, 526 Brackett JC, 460 Cecchin F, 71 Concha M, 648 Adler SW, 476 Baron JA, 971 Bramucci E, 675 Celestin C, 1184 Connelly CM, 291 Aepfelbacher FC, 743 Baroni M, 282 Braunwald E, 232, 621, Centamore G, 436 Conti JB, 952 Aguirre FV, 111, 559 Bartakova H, 146 977 Cercek B, 232 Contrada RJ, 503 Ahmed M, 1135 Bashore TM, 58, 485 Bredie SJH, 348 Cerino M, 535 Coppola A, 436 Ahn C, 182, 514, 837 Bassand JP, 330 Breikss A, 767 Chaitman BR, 865, 977 Corbett JR, 720 Airaksinen KEJ, 877 Bateman TM, 718 Bremner S, 516 Chakko S, 184 Cornel JH, 287, 505, 1112 Akasaka T, 639 Bates ER, 1015 Brezden OS, 1088 Chakraborty B, 23 Corretti MC, 783 Akhtar M, 251, 516 Bauman JL, 1184 Brickner ME, 191 Chan CNS, 23 Costagliola D, 425 Alaupovic P, 1124 Beekman RH, 370, 642 Brignole M, 518 Chan WM, 189 Costante AM, 675 Alboni P, 91 Belardinelli L, 952 Brinker JA, 1170 Chang M-H, 317 Counihan PJ, 1056 Alejos JC, 1048, 1294 Belgrave G, 1120 Brouwer J, 796 Chang M-S, 186, 1239 Cowan J, 174 Alexander M, 555 Belhassen B, 316, 511 Brown EJ Jr., 596, 1184 Chapman FW, 1135 Cowell RPW, 415 Algom M, 1272 Beller GA, 228, 653 Brown LE, 621 Chapman J, 511 Cragg D, 573 Allen JK, 1092 Ben-Zur U, 1229 Browne KF, 987 Chapman PD, 1135 Crake T, 725 Allen JW, 960 Bender AM, 971 Brugada P, 698 Chatellier G, 498 Craven TE, 455 Allison DB, 956 Benditt DG, 476 Brundage BH, 1088 Chauvel C, 425 Crea F, 224, 683 Almange C, 411 Benedict C, 354 Buis B, 845 Cheirif J, 982 Cross DB, 172 Almon L, 738 Benedict CR, 1151 Buja G, 1038 Chelliah N, 987 Crouse JR Ill, 455 Amery A, 53 Benson Jr DW, 405 Bultas J, 1102 Chelton S, 503 Crow RS, 1233 Amir G, 511 Berder V, 411 Burgan R, 736 Chen C-H, 1239 Crowley JJ, 633 Ammar A, 465 Berger M, 753 Burger AJ, 305 Chen C-Y, 186 Csanadi Z, 626 Amsterdam EA, 85 Bergillos F, 378 Burger L, 840 Chen S-A, 186 Cucchini F, 204 Anagnostopoulos C, 529 Berti S, 630 Burkhart GA, 213 Cheng C-C, 186 Curtis AB, 952 Anders RJ, 1102 Beyar R, 285 Burnett RE, 1019 Chern M-S, 302 Cutler NR, 1102 Anderson JW, 1196 Beyer J, 645 Burns TL, 754 Cherrier F, 330 Czeizel AE, 1187 Anderson K, 559 Bhadha K, 963 Burrows L, 210 Chevrolet J-C, 842 Anderson ST, 617 Biagini A, 282, 630 Burt R, 568 Chew PH, 596 d’Avila A, 698 Angoli L, 675 Bianchi R, 630 Burton E, 1012 Chiang BN, 186 D’Cruz IA, 308 Anguita M, 378 Bigger JT Jr., 1145 Burton JR, 936 Chiang C-E, 186 Dagenais GR, 1189, 1224 Annoura M, 93 Bigras J-L, 101 Burton Kd, 157 Chikamori T, 508 Daikoku S, 577 Antman EM, 391 Bilianou HI, 293 Butcher RJ, 390 Chin AJ, 61 Dalery K, 1107 Appleton CP, 191 Binder M, 913 Byington RP, 455 Chiou C-W, 186 Daliento L, 1038 Arakawa K, 93 Bisson G, 535 Byrd D, 778 Chiriatti GP, 810 Dallapiccola B, 95 Aranki SF, 553 Bittar N, 1184 Chisholm RJ, 1070 Damaraju S, 1181 Arbab AS, 324 Blackburn H, 316, 1096 Califf RM, 559, 871,1019 Cho SK, 88 Danchin N, 330 Arbustini E, 675 Blanck Z, 251, 516 Callans DJ, 297, 1140 Choi BW, 526 Danford DA, 587 Arizon JM, 648 Blanco J, 648 Calvin JE, 1003 Cholesterol Treatment Daniel WC, 199 Armstrong PW, 1007 Blank R, 956 Camarano G, 215 Trialists’ Collaboration, Danzi G, 675 Armstrong WF, 707, 982 Block PC, 601, 1170 Cambillau M, 127 1130 Danzi GB, 855 Arnese M, 287 Bloom MF, 1116 Cambou J-P, 1202 Chomka EV, 374, 973 Daoud E, 255, 628 Arnold JMO, 621 Bloomfield DM, 1145 Camenzind E, 772 Chou P, 1239 Daubert C, 411 Aronow WS, 182, 302, Blumenthal JA, 1019 Cameron T, 665 Chouraqui P, 321 Davidson MH, 34 514, 837, 1273 Blumenthal M, 596 Camm Ad, 1023 Christian TF, 718 Davies GJ, 725 Ashcom TL, 482 Blumenthal RS, 1092 Campolo L, 675 Chua S, 302 Davignon A, 101 Atakr Multicenter Investi- Boden WE, 1120 Canby RC, 548 Chuang YC, 1267 Davignon J, 1107 gators Group, 50 Boersma E, 287 Cannistra LB, 890 Chung HK, 189 Davis BR, 621 Atger V, 127 Bohlender J, 498 Cannon CP, 232, 977 Chung J, 1229 Davis E, 1244 Atkins DL, 544 Bom H-S, 535 Cannon RO ill, 40, 264, Chung MK, 18 Davis KB, 220 AVID Investigators, 470 Bond MG, 455 443, 1274 Cianflone D, 224 Davis V, 232, 615 Avula SB, 1003 Bondestam E, 767 Cantin B, 1189, 1224 Ciavatti M, 505 Day RW, 196 Awan NA, 1102 Boni E, 1042 Cantwell JD, 1081 Cipriani M, 855 de Bruin TWA, 348 Bonow RO, 526 Capone R, 1244 Ciudad M, 378 De Chiara F, 855 Babcock K, 237 Boomsma F, 796 Caputo GR, 365 Clarkson PBM, 206 de Feyter PJ, 287, 772 Bach DS, 982 Borer JS, 523 Caracciolo EA, 111 Clegg L, 237 de Freitas C, 744 Bach RG, 111 Bornemeier RA, 61 Cardello FP, 45 Clerico A, 630 de Jaegere P, 772 Bacharach SL, 526 Borzak S, 1211 CARE Investigators, 621 Cody RJ, 822 de la Hera A, 947 Badar DM, 264 Boscarini M, 675 Carini G, 535 Coghlan JG, 415 De Pasquale M, 280 Baggett JC, 98 Bosi G, 1277 Carpenter B, 237 Cohen A, 425 De Place C, 411 Baik SH, 88 Bosner MS, 18, 157 Carter S, 141 Cohen JD, 831 de Roos A, 845 Baird M, 555 Bossi IM, 308 Cartwright D, 101 Cohen-Solal A, 998 De Servi S, 675 Bajaj AK, 908 Bot H, 1270 Casazza GA, 85 Cohn CD, 840 Deal B, 587 Bakalyar D, 993 Botti G, 810 Case C, 587 Cohn PF, 840 Deal BJ, 405 Bakr 0, 628 Bottoni N, 518 Casino PR, 40 Cokkinos DV, 293 Decker PJ, 104 Balady GJ, 890 Bouher NJ, 971 Caso R, 335, 850 Colleran JA, 312 deFilippi CR, 191 Balasingam S, 563 Bouilliec M, 842 Caspi A, 763 Collins D, 1196 Dehmer GJ, 170 1296 THE AMERICAN JOURNAL OF CARDIOLOGY® VOL. 75 JUNE 15, 1995 Delemarre BJ, 1270 Eigler NL, 539 Francis G, 354 Giudici V, 620 Hatfield B, 360 Demacker PNM, 348 Eisenberg SJ, 687 Francis GS, 1151 Giustina A, 1042 Hattori T, 14 DeMaria AN, 282 El-Gamal A, 956 Francis M, 1244 Giustina G, 1042 Hawkins CM, 621 Demirovic J, 1096 Elam MB, 1196 Franco M, 436 Glamann DB, 77 Hawkins JA, 533, 606 DeNardo SJ, 1083 Eldar M, 687 Franke S, 1033 Glazier S, 778, 1069 Hayashi T, 122 Denys BG, 1056 Elhendy A, 287, 505, 1112 Franz MR, 687 Glogar HD, 913 Haze K, 577 Department of Veterans Elias WJ, 617 Franzen P, 913 Glueck CJ, 132 Healy S, 993 Affairs HDL Intervention Elkayam U, 521 Fraser GE, 141 Gold MR, 460, 1158 HEART Study Executive Trial Study Group, 1196 Ellenbogen KA, 45 Freedman SB, 81, 942 Goldberg AD, 1211 Committee, 1173 deRuyter H, 1923 Ellestad MH, 316 Freeman MR, 1007 Goldberg Al, 793 Hecht A, 703 Deshpande S, 251, 516 Elliott JM, 172 Freiman J, 213 Goldberg SJ, 746, 971 Hecht SR, 753 Després J-P, 1189 Ellis S, 829 French WJ, 1088 Goldhaber SZ, 316 Hedén B, 929 Dessouki A, 665 Ellis SG, 871 Friedman H, 573 Goldman JH, 494 Heesch CM, 360 Detrano RC, 1088 EPIC Study Investigators, Friedman PL, 1023 Goldsmith R, 1282 Heidenreich PA, 365 Devereux RB, 157, 1028 559 Friedman RA, 71, 587 Goldstein DJ, 968 Heider A, 194 Devlin W, 573 Epperlein S, 904 Frigerio M, 855 Goldstein MR, 319 Heinle SK, 58 Devries S, 973 Epstein MR, 1278 Fu M, 302 Golinko RJ, 1289 Held C, 1 Dey HM, 1214 Epstein S, 182, 514, 837, Fuca G, 91 Gomez J, 956 Hellemans IM, 489 Dhala A, 251, 516 1273 Fujikawa K, 1284 Gondo N, 93 Heller GV, 665 Di Carlo D, 637 Erbel R, 204 Fujita M, 728 Gonzalez J, 850 Heller K, 511 Di Mario C, 772, 1177 Eriksson B, 241 Fujita N, 365 Gonzalez R, 687 Hennekens CH, 1173 Di Primo A, 436 Espeland MA, 455 Fujiwara R, 122 Goodwin TM, 521 Henson DJ, 418 Dias VC, 45 Espino A, 648 Fukai D, 1162 Gordon R, 724 Henzlova M, 1244 Diebold B, 425 Ewing H, 886 Fukuda N, 1286 Gorgels AP, 1206 Heo J, 396, 759, 963, Diegoli M, 675 Eybalin M-C, 535 Furberg CD, 455 Goris GB, 34 1140 Dige-Petersen H, 659 Eysmann SB, 201 Furman S, 1229 Gosselin G, 1244 Herson S, 977 Diggs P, 840 Furuno T, 508 Goto Y, 577 Hertz RP, 214 Digilio MC, 95 Faas FH, 1196 Fyfe BS, 210 Gotsman MS, 30, 84 Heublein B, 703 DiMarco JP, 1135 Faber TL, 720 Gottlieb CD, 297, 1140 Heymsfield SB, 956 DiMarzio D, 963 Fagard R, 53 Gadler F, 919 Gottlieb SS, 460, 1158 Hidalgo L, 648 DIMT Study Group, 796 Fahrenbach MC, 258 Gadsbail N, 659 Gourgon R, 998 Higgins CB, 365 Dinwoodie A, 936 Faletra F, 855 Gaggioli G, 518 Gow R, 744 Hill JA, 75 Diodati JG, 443 Falk RH, 551, 1081 Gagnon MM, 291 Grassi V, 1042 Hillis LD, 77, 199, 939, Distante A, 282 Faraggi M, 998 Galassi A, 436 Grasso M, 675 1250 Dobb GJ, 693 Fasani R, 675 Galassi AR, 436 Gray J, 157 Hilton D, 555 Dodi C, 810 Faus JM, 335 Galindo AJ, 1048 Grayburn PA, 1914 Himbert D, 998 Dodo H, 1294 Favilli S, 1028 Gallagher D, 956 Green MH, 299 Himeno E, 1265 Doevendans PA, 1206 Fay WP, 707 Gallardo A, 378 Greenberg B, 1151, 1244 Himmrich E—, 904 Doherty RM, 624 Feldman JM, 485 Gamra H, 960 Greene HL, 1135 Hinohara T, 1015 Doherty TM, 1088 Feliciano Z, 1158 Gandhi P, 956 Gregorini L, 308 Hisanaga T, 1162 Doi Y, 508 Fenelon G, 698 Garbe M, 944 Griffin J, 1267 Hjemdahl P, 1 Domanski M, 829 Ferraro P, 280 Gardner M, 1244 Griffin JC, 687 Ho SY, 746 Donato L, 630 Ferrick KJ, 1229 Gariepy J, 127 Grimm M, 913 Hochreiter C, 523 Donchez LJ, 418 Ferriéres J, 1202 Garratt KN, 1015 Grines C, 573, 993 Hockings BEF, 693 Donohue B, 987 Filutowski K, 1166 Garson A Jr., 950 Grines CL, 778, 987 Hod H, 321 Donohue TJ, 111 Fineberg N, 568 Garyfallidis P, 505 Gronda E, 855 Holly RG, 85 Donovan KD, 693 Finkbeiner WE, 687 Gaspoz J-M, 842 Gross J, 1229 Holmes DR, 1170 Dooris M, 778 Finocchiaro ML, 224 Geist M, 30 Grossman E, 1072 Hong MK, 731 Dorros G, 1051 Fioretti PM, 287, 505, Geleijnse ML, 1112 Grover F, 237 Hongo M, 246 Dougherty SM, 670 1112 Gelperin K, 596 Guenthard J, 814 Honma H, 324 Douglas JS, 886 Fiscella A, 436 Gemelli A, 505 Guetta V, 1274 Hoogendoorn LI, 845 Douglas PS, 201, 624 Fishberger SB, 1278 Genest J Jr., 1107 Gunawan SA, 23 Hoon TJ, 1184 Drinkwater D, 403, 1048 Fisher JD, 1229 Georgiou D, 1088 Guslits B, 859 Horton RP, 548 Drinkwater DC, 1294 Fisher LD, 865 Gerbaux A, 383 Gutgesell HP, 818 Horwood L, 255 Drory Y, 835 Fishman LS, 104 Gerlisath LM, 746 Guyon P, 425 Hovgaard D, 296 Drozdz J, 204 Fisman EZ, 835 Gersh BJ, 220 Howes LG, 582 Dubrey S, 1081 Fitzpatrick D, 736 Ghazzal ZMB, 886, 1012 Haab D, 913 Hsu PC, 137 Dudley VS, 1124 Flachskampf FA, 1033 Gheen KM, 66 Haider AW, 725 Hsu T-L, 186, 1239 Dufek C, 1051 Fleg JL, 788 Gheno G, 204 Haluska B, 805 Huang SKS, 50 Dujovne CA, 34 Fleiss JL, 1145 Gianfranchi L, 518 Hamer AW, 172 Hui JCK, 840 Dullet NK, 687 Fletcher BJ, 738 Gibbons Ru, 718 Hamer HPM, 489 Huikuri HV, 877 Dunlay MC, 793 Fletcher GF, 738 Gibson RS, 653 Hammermeister KE, 237 Hummel JD, 255, 628 Dunselman PHJM, 796 Fletcher RD, 312 Gibson W, 718 Han J, 1145 Hundley WG, 1250 Duval RD, 118, 180 Foerster EH, 77 Gil R, 772, 1177 Hancock HL, 308 Hung J-S, 302 Duvernoy WFC, 551 Fogelman R, 763 Gilbertson D, 1096 Hanet C, 383 Hurst JW, 832 Dzavik V, 936 Foley JB, 1070 Gilligan DM, 264 Hanna RD, 670 Hussain N, 443 Formigari R, 637 Gilon D, 30 Hannan P, 1233 Hgilund-Carlsen PF, 659 Eagle K, 829 Forrester JS, 539 Giménez D, 378 Hanrath P, 1033 Ebels T, 489 Fosinopril Heart Failure Gimple LW, 215 Hansen PR, 296 lervasi G, 630 Echt DS, 1135 Study Group, 596 Ginzton LE, 934 Harrison JK, 58, 485 Igawa A, 728 Edenbrandt L, 929 Foster E, 365 Gioia G, 396, 759 Hartford M, 767 |kaheimo MJ, 877 Edner M, 919 Fostinis YP, 293 Giordano A, 280 Hartzler GO, 315, 987 Ikeda Y, 324 Eichhorn EJ, 191, 360 Fournier A, 101 Giordano B, 280 Hasin Y, 30 ligenfritz JP, 596 Eichler H-G, 913 Fraley K, 71 Giral P, 127 Hassanein H, 633 lisley CDJ, 415 AUTHOR INDEX 1297 Inada M, 14 Kashyap ML, 1196 Krum H, 1282 Levasseur A, 535 Manja G, 174 Incomplete INfarction Trial Kaski JC, 400, 725 Kubo S, 354 Levenson J, 127 Mann D, 1196 of European Research Kass RM, 137 Kubo SH, 1151 Lever HM, 805 Manning WJ, 624 Collaborators Evaluating Kastelein JUP, 348 Kudenchuk PJ, 1135 Levine S, 418 Manuel M, 396 Prognosis Post-Throm- Kataoka H, 424 Kugler JD, 587 Li HF, 1250 Manzoli A, 683 bolysis (diltiazem) Katz JP, 840 Kumagai K, 93 Liang C-S, 354, 1151 Marchlinski FE, 297, 1140 (INTERCEPT) Research Katz SE, 201, 624 Kuo H-S, 1239 Liberti F, 436 Marco J, 987 Group, 1120 Kaul S, 166, 215 Kurisu S, 394 Lichtlen PR, 703 Marcoux L, 360 Inoue H, 728 Kawachi |, 882 Kuroiwa A, 1265 Lie KI, 489, 796 Marcovitz PA, 707 Irani MS, 422 Kawagoe T, 394 Kutsumi Y, 122 Lieberman EB, 58 Marcus ML, 754 lranmanesh A, 1196 Kawashima T, 1265 Kwon KS, 88 Liebrich A, 904 Margulis A, 993 Iriarte M, 335, 850 Kay R, 189 Kyo S, 161 Liebson PR, 1233 Marian AJ, 1181 Isabel-Jones JB, 1048 Kearney K, 924 Lien W-P, 651 Marinelli G, 620 Ishihara M, 394 Keeley EC, 939 L’Abbate A, 282 Lilleberg J, 1061 Marino B, 95 Ishihara T, 324 Keeling PJ, 494 Labanti G, 535 Lin J-L, 651 Mark DB, 1019 Iskandrian AS, 316, 396, Kemp DL, 751 Lablanche JM, 330 Lin L, 137 Maron BJ, 827 759, 963, 1175 Kennedy JW, 220 Lacquet LK, 734 Lin S-J, 1239 Martin AB, 950 Ismail G, 934 Kent KM, 177, 398, 731, Lacy CR, 503 Lincoff AM, 871 Martin GR, 801 Israel DH, 210 1267 Lahiri A, 1102 Linde C, 919 Martinsson A, 241 Ito S, 1286 Kerber RE, 544, 754 Laks H, 403, 1048, 1294 Lionetti F, 280 Marwick TH, 805 Itoh A, 577 Kern MJ, 111 Lam W, 582 Lippman N, 591 Maseri A, 224, 683 luchi A, 1286 Kessler DJ, 548 LaManca JJ, 418 Lipsitz LA, 291 Mathiak L, 1051 lwasaka T, 14 Kessler DK, 184 Lamarche B, 1189 Little T, 174 Matsumura M, 161 Kessler KM, 184 Lampe P, 237 Litvack F, 1012 Matsumura Y, 508 Jacks M, 573 Ketterer MW, 1211 Landau C, 77, 199, 939, Litwin PE, 617 Matsuo K, 93 Jadhav P, 305 Khaghani A, 415 1250 Livolsi B, 1038 Maurer MS, 788 Jadonath RL, 297 Kilcoyne CM, 40 Lane DM, 1082, 1124 Lo E, 934 Mavrogeni SI, 400 Jaff MR, 1051 Kim EJ, 88 Laney R, 529 Lolli G, 518 Maynard C, 617 Jain A, 1051 Kim SG, 1229 Lang JE, 132 Lopez de Argumedo M, Mayo-Smith M, 1196 Jang I-K, 601 Kim SH, 88 Lange RA, 77, 199, 939, 335, 850 Mazzola F, 50 Janousek J, 146 Kim SS, 88 1250 Lopez-Miranda J, 648 McCabe CH, 977 Jansen W, 194 Kimura H, 324 Langer A, 1007 Lotan C, 30, 84 McCarthy KE, 526 Jarmakani JM, 1048 King SB Ill, 886, 1012 Langer G, 555 Louis WJ, 582 McCrindle BW, 101 Javier SP, 177 King JC, 1187 Langlais F, 535 Lovis C, 842 McGhie Al, 720 Jayaweera AR, 166 Kinoshita M, 1162 Laniado S, 511 Lowe JE, 485 McGough EC, 533, 606 Jazayeri MR, 251, 516, Kinzey J, 754 Lanza GA, 683 Lu C, 810 McGovern ME, 455 1135 Kirlin P, 1151 Lariviére L, 555 Lu D, 312 McGovern PG, 1096 Jenkins 0, 711 Kirlin PC, 354 Latour Y, 1107 Lucreziotti S, 675 McGuire MA, 431 Jennison SH, 751 Kirschner E, 753 Lau FYK, 960 Ludomirsky A, 408, 541 McKenna WJ, 494 Jensen BH, 659 Kirshenbaum JM, 977 Lau KW, 23 Luepker R, 1096 McKenzie JP, 18 Jensen EE, 1083 Kisslo J, 58 Laubach CA Jr., 390 Luke R, 141 McKinnon BE, 98 Jhee SS, 1102 Kisslo KB, 58 Laughlin LO, 1124 Lumley MA, 1211 McNamara D, 535 Jian H, 494 Kitaoka H, 508 Laurent M, 411 Luo H, 539 Meadaa R, 174 Jikuhara T, 14 Klappacher G, 913 Lauria SS, 460 Lupien P-J, 1189, 1224 Megnien JL, 127 Jimenez-Pereperez JA, 648 Klein GJ, 626 Lavie CJ, 340, 743, 940 Lurie KG, 476 Mehra MR, 853 Job FP, 1033 Klein HO, 213 Lawson WE, 840 Lusa A-M, 535 Mehrabi M, 913 John B, 174 Klein L, 1012 Laxer RM, 744 Lussier-Cacan S, 1107 Melchionda S, 95 Johns JP, 482 Klein LW, 1003 Layman TE, 551 Luy L, 744 Mele D, 91 Johnson AD, 316, 1083 Kligfield P, 523, 1166 Lazar JM, 1056 Lynch JM, 196 Menapace FJ, 390 Johnson JE, 482 Klinke WP, 1170 Lazzeroni E, 810 Lystash JC, 653 Menard J, 498 Johnson JL, 1135 Kloner RA, 615, 1292 Le Guludec D, 998 Menozzi C, 518 Johnson R, 237 Knight JA, 390 Lebtahi R, 998 Mabo P, 411 Mercando AD, 182, 514, Johnsrude CL, 71 Knight-Gibson C, 1124 Leclerc J-M, 101 MacDonald LL, 859 837, 1273 Johnstone D, 354 Kocis KC, 642 Lee K-Y, 693 MacDonald TM, 206 Merion RM, 707 Johnstone DE, 1151 Kodali U, 724 Lee KH, 88 Mach F, 842 Meshack BM, 1250 Jordan J, 743 Koh KK, 88 Lee KL, 871 Machac J, 210 Messerli FH, 743 Jordan M, 232 Koh P, 23 Lee LV, 7 Machecourt J, 330 Meyer J, 645, 904 Joubert GI, 636 Koh TH, 23 Lee S-H, 186 MacLean A, 596 Michael TAD, 563 Juilligre Y, 330 Kohn R, 1244 Legault SE, 1007 Macleod C, 206 Michel X, 383 Juliard J-M, 998 Koizumi K, 324 Lehtonen L, 1061 MacNeil DJ, 1023 Michler RE, 968 Kolovou GD, 293 Leichtman AB, 707 MacNeill SE, 1211 Milani RV, 340, 940 Kaan GL, 734 Konkel K, 736 Leimberger JD, 1019 Maeda K, 1162 MILIS Study Group, 615 Kadish AH, 687 Konstam MA, 822, 1151 Leon MB, 177, 398, 526, Maeda Y, 1162 Miller C, 210 Kageji Y, 1286 Kopelen HA, 1256 731, 1267 Maeno M, 577 Miller DD, 535 Kahaly G, 645 Koshino Y, 122 Leor J, 1292 Maffei S, 282 Miller LW, 751 Kahn JK, 724, 1069 Koshman ML, 955 Lepor N, 539 Mahmarian JJ, 1116 Miller M, 736, 1282 Kaida M, 14 Koster RW, 1270 Lerman BB, 591 Mahony C, 924 Mills RM Jr., 98 Kaku T, 1265 Kostis J, 1244 Lesh MD, 687 Malacky T, 698 Mingarelli R, 95 Kamalesh M, 305 Kostis JB, 503 Lesser J, 849 Mallavarapu C, 1140 Minich LL, 533, 606 Kantoch MJ, 862 Kottke BA, 317 Letac B, 739 Man in ’t Veld AJ, 796 Mintz GS, 177, 398, 731, Kaplan S, 1048 Kouchoukos NT, 157 Lethen H, 1033 Man KC, 255, 628 1267 Kaplinsky E, 321 Krall J, 174 Lette J, 535 Manabe K, 1286 MISNES Investigators, Karr SS, 801 Kramer-Fox R, 1028 Leuenberger U, 299 Mancini DM, 418 1277 Karwatowski SP, 529 Kronzon |, 304 Lev E, 511 Mangiavacchi M, 855 Mitchell AG, 415 1298 THE AMERICAN JOURNAL OF CARDIOLOGY® VOL. 75 JUNE 15, 1995 Mitchell RE, 98 Nawras A, 956 Papademetriou V, 312 Pryor AD, 617 Rothbaum D, 987 Mittleman RS, 50 Nevo E, 285 Paparella N, 91 Puchrowicz-Ochocki S, Rothbaum DA, 1012 Mitty HA, 1289 Nevo S, 285 Paquet N, 535 987 Rouleau J-L, 621 Mitusch R, 944 Newell JB, 601 Parilak L, 299 Pugliese S, 630 Rovai D, 282 Miwa K, 728 Ng A, 23 Park HB, 88 Rowland DG, 818 Miyabo S, 122 Ng CK, 1214 Park SJ, 88 Quattrocchi G, 855 Rozenman Y, 30, 84 Miyagi Y, 728 Niccoli L, 675 Parrillo JE, 1003 Quish A, 210 Rubal BJ, 482 Miyahara T, 449 Nicholls G, 967 Parsons L, 865 Qurashi MA, 1003 Rubins HB, 1196 Miyazaki S, 577 Nickele GA, 670 Partouns J, 1206 Quyyumi AA, 40, 264, 443 Ruidavets J-B, 1202 Miyoshi K, 1284 Nicklas J, 354, 1151 Pasceri V, 224 Ruiz CE, 960 Moatti N, 127 Niebauer M, 255, 628 Pasquini L, 637 Rabinowitz B, 321 Ruiz M, 378 Mochizuki S, 324 Niederle N, 194 Patel KM, 801 Radice M, 620 Russell J, 396, 759 Modi R, 936 Nielsen JR, 659 Pattynama PMT, 845 Rafferty M, 546 Rutala WA, 170 Mohiaddin RH, 529 Nieminen MS, 1061 Paul T, 146 Raffoul H, 425 Rutan GH, 1196 Mohr-Kahaly S, 645 Nishinaka Y, 449 Paul VE, 415 Ragosta M, 215, 1056 Rutherford J, 621 Moleiro F, 947 Nishio H, 122 Pavri BB, 1145 Ramaciotti C, 61 Ryan TJ, 865 Molinero E, 335 Nishioka T, 539 PCVMETRA Group, 127 Ramee SR, 853 Rydén L, 919 Moliterno DJ, 559 Niskanen RA, 1135 Pearlman AS, 316 Rao G, 563 Molnar J, 537 Nitsch J, 651 Pediatric Electrophysi- Ratnayake WMN, 424 Sable CA, 801 Montague TJ, 936 Nixon PGF, 1187 ology Society, 587 Rautaharju P, 1233 Sabry AF, 611 Mooney J, 849 Nomof N, 1187 Pedini |, 91 Ravelli ACJ, 489 Sackett MC, 228 Mooney MR, 849 Nonogi H, 577 Pedrotti P, 683 Reddy PS, 1056 Sacks FM, 621, 1263 Moore JA, 111 Nootens M, 374 Peleg E, 1072 Reeves JT, 66 Sacks J, 237 Moore JO, 485 Nordlander R, 919 Pelliccia A, 827 Rehngqvist N, 1 Sada M, 934 Moorjani S, 1189, 1224 Norris RM, 172, 967 Penilla MB, 746 Reich JS, 863 Saenz R, 850 Morady F, 255, 628 Novelli G, 95 Pepine C, 1244 Reis G, 707 Safavi F, 1181 Morbini P, 675 Nowak B, 904 Perez-Jimenez F, 648 Reiter MJ, 1135 Safian RD, 778 Moreyra AE, 503 Noyez L, 734 Perloff JK, 1294 Reller MD, 611 Sagastagoitia D, 335 Morgan P, 237 Perondi R, 308 Remmen GH, 734 Sahn DJ, 611 Morin Y, 555 O'Brian Smith E, 71 Perry JC, 71, 950 Remole SC, 476 Saino A, 308 Morise AP, 118, 180 O'Keefe J, 987 Peshock RM, 1250 Rengo R, 280 Sakaguchi S, 476 Moroe K, 93 O’Keefe JH Jr., 718 Peter CT, 137 Repetto S, 675 Salustri A, 287, 505 Morozzi L, 810 O'Malley CJ, 890 Peters MA, 859 Rice MJ, 611 Salvatore L, 282 Morris N, 26 O'Neill W, 573 Peters NS, 400 Rich MW, 18 Samson RA, 544 Morris-Thurgood J, 415 O'Neill WW, 778, 987, Peters RW, 1158 Rich S, 374, 973 Sanaullah S, 511 Morrison DA, 237 993, 1069 Petersen CL, 659 Richards DAB, 431 Sanderson JE, 189 Mosca RS, 370, 408 O'Sullivan M, 365 Peterson C, 929 Riggio DW, 1158 Sandhu SK, 370 Moser SA, 50 Oddone D, 518 Peuhkurinen KJ, 877 Rigolin VH, 485 Sansoy V, 166 Moss AJ, 950 Oettinger M, 763 Pezzano A, 855 Rihal CS, 220 Santoni J-P, 1120 Mosseri M, 30, 84 Ogawa M, 93 Pfeffer MA, 621, 1173 Riley MF, 624 Santoro G, 637 Motro M, 1072 Ohlsson M, 929 Phillips BG, 1184 Rinaldi M, 1028 Saoudi N, 739, 947 Mower MM, 553 Ohman EM, 871 Phillips JC, 34 Rita B, 630 Sarkarati M, 201 Moye L, 214 Oka Y, 1265 Picano E, 810 Rittner R, 929 Sasaki M, 1286 Moye LA, 621 Oki T, 1286 Picard M, 535 Rizik DG, 993 Satler LF, 177, 398, 731, Moyé LA, 1116 Okin PM, 523 Pichard AD, 177, 398, Robbins ML, 503 1267 Mueller HS, 977 Okura H, 639 731, 1267 Robert AR, 383 Sato H, 394 Mueller L, 886 Oliphant TH, 34 Pieper EPG, 489 Roberts WC, 106, 151, Satou T, 324 Miigge A, 703 Olsen MA, 237 Pilo A, 630 1075 Saul JP, 587, 1278 Muller DWM, 982, 1015 Omoto R, 161 Pines A, 835 Robins SJ, 1196 Savard D, 555 Muller J, 615 Ong JJC, 137 Pires LA, 50 Robinson JL, 950 Savas V, 724, 1069 Munson JT, 624 Oppenheim B, 568 Pirwitz MJ, 77 Robiolio PA, 485 Saxon LA, 403 Murga N, 335, 850 Orban Z, 859 Pitt B, 1023 Rocha-Singh K, 26 Sayed-Taha K, 718 Murthy S, 210 Ormaetxe J, 850 Plesch K, 913 Rocha-Singh KJ, 344 Scambler P, 95 Musumeci S, 436 Ormiston JA, 172 Plotnick GD, 783 Rockenbauer M, 1187 Scarfé S, 91 Myerburg Ru, 947 Orsmond GS, 196 Pollak SJ, 45 Rodda BE, 1023 Schatz RA, 26, 344, 1083 Myers MG, 318 Oselladore L, 1038 Pollick C, 652 Roelandt JRTC, 287, 505, Schauwecker D, 568 Oster Z, 840 Poloniecki J, 494 772, 1112 Schectman G, 1196 Nadeau C, 555 Overlie P, 987 Pomidossi G, 308 Rolnitzky LM, 1145 Scheinman MM, 687, Nagabhairu R, 1229 Oz MC, 968 Poole-Wilson PA, 400 Roman CA, 548 1135 Nagueh SF, 1256 Ozaki Y, 772 Popma JJ, 177, 398, 731, Roman MJ, 157, 1028 Scheldewaert R, 1120 Naheed ZJ, 405 1267 Romanelli G, 1042 Schlesinger Z, 1272 Nakai T, 122 Pacher R, 913 Porcu E, 675 Rome JJ, 801 Schmitz W, 703 Nakamura S, 14 Packer M, 1282 Poschmann G, 904 Romeira L, 529 Schmiicker G, 944 Nakamura T, 324 Pados G, 1187 Pous J, 1202 Rosano GMC, 400 Schoenfeld MR, 304 Nakashima Y, 1265 Page RL, 548 Powell D, 237 Rose EA, 968 Scholz H, 703 Nakatani S, 805 Pahim 0, 617, 929 Power BM, 693 Rosen SD, 725 Schon F, 204 Nakatsuka T, 246 Painter JA, 398, 731 Powers ER, 215 Rosenberg HC, 636 Schreiber TL, 993 Nandate H, 1265 Palacios IF, 601 Powers J, 759 Rosenqvist M, 919 Schrott HG, 34 Narayan P, 312 Palazzo G, 436 Pratt CM, 214, 1023, Rosenschein U, 871 Schwabe K, 944 Nash DT, 621 Pancholy S, 1140 1116, 1244 Rosenthal JE, 537 Schwartz PJ, 1023, 1277 Nasmith JB, 977 Pantoja P, 237 Pressel MD, 460 Rosenthal T, 1072 Schwartzman D, 297, Natale A, 251 Panza JA, 40, 264 Pribill 1, 913 Ross DL, 431 1140 Natterson PD, 403 Panza JA, 1274 Prineas RJ, 1233 Roth D, 555 Scott CH, 104 Nava A, 1038 Paoli F, 282 Probstfield J, 354 Roth JA, 1229 Sekiguchi M, 246 AUTHOR INDEX 1299 Seldomridge JA, 968 Staessen J, 53 Defibrillation Investiga- Van Hare GF, 587 Wilkins ML, 617 Selhub J, 1107 Staggers J, 738 tors, 1135 van Veldhuisen DJ, 796 Willard JE, 77, 199, 939, Selvester RH, 617 Stalenhoef AFH, 348 The Diabetes Control and Vandam D, 993 1250 Serruys PW, 772, 1177 Stamato T, 744 Complications Trial Vandenberg BF, 754 Willerson JT, 720 Serwer GA, 408 Stambler BS, 45 Research Group, 894 Vanoverschelde J-LJ, 383 Willett DL, 191 Sestier F, 621 Stanford W, 754 Theisen ME, 1211 Vauthier M, 411 Williams BF, 172 Sexon RG, 422 Stapleton DD, 853 Thiene G, 1038 Ventura HO, 853 Williams RG, 1048, 1294 Shaddy RE, 196, 533, 606 Stark CA, 754 Thijs L, 53 Verani MS, 1116 Williamson BD, 255, 628 Shah PK, 232 Starkey IR, 1120 Thomas JD, 805 Vermilion RP, 408, 541, Wilshire-Clementc M, 1282 Shah V, 973 Stazi F, 683 Thompson B, 977 642 Wilson JS, 58 Shalev Y, 763 Steffens J, 365 Thompson PD, 258 Verreault J, 535 Wilt TJ, 1196 Shapira |, 835 Steg PG, 998 Thompson S, 141 Verunelli F, 282 Wolf D, 237 Shapiro LM, 633 Stein EA, 34 Thrombolysis and Angio- Vetter JM, 61 Wolfkiel CJ, 374, 973 Shapiro SM, 934 Stein KM, 591 plasty in Myocardial Vigorito C, 280 Wong A, 189 Sharma SK, 210 Stein L, 568 Infarction Study Group, Villa Y, 511 Wong C, 344 Sharpe N, 141 Steinberg JS, 956 871 VillaNueva C, 237 Wong C-K, 81, 942 Shaw P, 132 Steinman RC, 1145 Tice FD, 58 Viskin S, 511 Wong KS, 189 Shawaryn GG, 34 Steinmetz A, 1072 TIMI 6 Investigators, 7 Visser CA, 489, 1270 Wong M, 465 Shechter M, 321 Stelken AM, 751 TIMI III Investigators, 977 Vitek F, 630 Wong ND, 1088 Sheffield LT, 865 Stephan WJ, 1015 TIMI-4 Investigators, 232 Vlasses PH, 1184 Wong SC, 26, 398, 731 Shefrin EA, 788 Stevenson WGX, 403 Timmis G, 993 Vlietstra R, 987 Woo KS, 172, 189, 967 Sheikhzadeh A, 944 Stewart D, 1244 Ting C-T, 1239 Vogel RA, 736, 783 Wood MA, 45 Sheil MLK, 711 Stierie U, 944 Tobert JA, 862 Voigtlander T, 904 Woroszylska M, 1102 Sheldahl LM, 670 Stoli BC, 482 Todd E, 77 Vokonas PS, 882 Wu C-J, 302 Sheldon R, 955 Stone GW, 987 Todd JS, 546 von Birgelen C, 772 Wu J, 184 Shelton B, 1151 Stone MJ, 269 Topol EJ, 559, 871, 1170 von der Leyen H, 703 Wu T-J, 186 Shelton BJ, 354 Stramba-Badiale M, 1277 Torp-Petersen C, 659 Wyler F, 814 Shemesh J, 1072 Strasburger JF, 405 Torres F, 378 Waclawiw MA, 1274 Shen J, 18 Strauss WE, 45 Tousoulis D, 725 Wada A, 1162 Yabe T, 508 Shen Y, 886 Straznicky NE, 582 Towbin JA, 71 Wagner GS, 617 Yacoub M, 415 Shimada Y, 122 Strickberger SA, 255, 628 Tracy T, 132 Wagner NB, 617 Yamada E, 161 Shimatani Y, 394 Stubbe |, 305 Travin Ml, 665 Wagshal AB, 50 Yamada H, 1286 Shirani J, 151 Stylos L, 299 Treese N, 904 Wahlers T, 703 Yamada N, 577 Sholler GF, 711 Sugiura T, 14 Triedman JK, 1278 Waksman R, 886 Yancy CW, 191 Shorofsky SR, 1158 Sumimoto T, 14 Tristani FE, 670, 865 Waksmonski C, 291 Yashiro A, 1265 Shultz JJ, 476 Sundberg S, 1061 Tron C, 114 Waldo AL, 1023 Yee R, 626 Shumacher D, 956 Superko HR, 277 Tsai D-S, 186 Wallén NH, 1 Yeh K-H, 302 Siegel RJ, 539 Supino P, 280 Tse KK, 189 Walsh EP, 1278 Yetman AT, 636 Sieve-Smith L, 132 Svedenhag J, 241 Tsipouras P, 157 Walter JD, 963 Yi G, 494 Sigmon KN, 559, 871 Swan HJC, 1067 Tsutamoto T, 1162 Walters EG, 1120 Yim JM, 1184 Siguel EN, 424 Sweet CS, 793 Tung RT, 908 Wang J-K, 317 Yin FCP, 1239 Silberbach GM, 611 Swerdiow CD, 137 Turchi S, 630 Wang S-P, 186, 1239 Ylitalo KV, 877 Silka MJ, 587 Swor R, 1069 Turrini P, 1038 Wang T-L, 651 Yokota C, 577 Silverman DI, 157, 624 SWORD Investigators, Tuzcu EM, 601 Wang Y, 132 Yokota M, 449 Silverman ED, 744 1023 Tymchak WJ, 936 Warnica JW, 621 Yokoyama S, 936 Silverman ME, 460 Sylvén C, 241 Watanabe A, 324 Yong PG, 50 Simon A, 127 Uchikawa S, 246 Watanabe N, 246 Yoshida K, 639 Simonton CA, 45 Tabak SW, 539 Ueda A, 394 Watson DD, 653 Yoshida S, 1162 Singh BN, 465 Tabata T, 1286 Ukai M, 449 Watson KR, 1070 Yoshikawa J, 639 Singh HP, 180 Tacy TA, 541 Umans V, 772 Waugaman A, 237 Young JB, 1244 Smallhorn JF, 744 Tai C-T, 186 Umetani K, 324 Weaver WD, 617 Younis LT, 751 Smart FW, 853 Takano H, 324 Underwood R, 529 Wei JY, 201 Yousefi J, 151 Smith H, 1414 Takata J, 508 Underwood RS, 400 Weidmann B, 194 Yu A, 137 Snider AR, 642 Takenaka H, 246 Unger P-F, 842 Weiner DA, 865 Yu Q-T, 1181 Sobue T, 449 Takeuchi M, 14 Upshaw CB Jr., 651 Weintraub WS, 886, 1012 Yuasa F, 14 SOLVD Investigators, 354, Tamura K, 324 Urban P, 842 Weisman HF, 559 Yurgalevitch SM, 258 1151, 1244 Tan ATH, 23 Urcelay G, 408 Weiss AT, 30 Yusuf $, 354, 1151, 1244 Somerville J, 529 Tang ASL, 1135 Uretsky BF, 1056 Weiss JS, 537 Sommer RJ, 1289 Tang W, 1088 Uretz E, 1003 Weiss M, 1244 Soria F, 743 Tani LY, 533, 606 Uriarte P, 850 Weiss RM, 754 Zahger D, 232 Soroff HS, 840 Tannenbaum AK, 503 Urschel HC Jr., 863 Weiss ST, 882 Zak Z, 511 Soufer R, 1214 Tase M, 498 Uther JB, 431 Wellens HJJ, 1206 Zambrana JL, 648 Spagnolo D, 1277 Tateishi H, 394 Werns SW, 707 Zanchetti A, 308 Sparrow D, 882 Tatum JL, 535 Vaitkus PT, 79 West E, 237 Zareba W, 950 Specchia G, 675 Taylor AJ, 228 Vallés F, 378, 648 Weyrens FJ, 849 Zaret BL, 1214 Spiva H, 940 Teirstein PS, 26, 344, 1083 Valty J, 425 Wheeldon NM, 206 Zayas R, 378 Spodick DH, 315, 652 Teitelbaum J, 535 Van Alstine A, 85 White HD, 172, 278 Zelingher J, 30 Sprafka JM, 1096 Ten Cate FJ, 287, 505 Van Dantzig JM, 1270 White HJ Jr., 422 Zelis R, 299, 546 Sprinkle JW, 455 Teo KK, 936 van den Brink RBA, 489 Whitehead A, 1120 Zeppellini R, 204 Squire A, 210 Terrazzi M, 282 van der Geestc Ru, 845 Whitner JT, 738 Zhang HP, 960 Sra J, 251, 516 Thakur RK, 626 van der Wall EE, 845 Wiederaenders K, 315 Zheng ZS, 840 Sramek JJ, 1102 The BEST Steering Com- van der Werf T, 734 Wiener |, 403 Zmuda JM, 258 St. John Sutton M, 104 mittee, 1220 van der Zee R, 1206 Wijns W, 383 Zoghbi WA, 1256 Stadeager C, 659 The Biphasic Waveform van Domburg RT, 1112 Wilke NA, 670 Zuppiroli A, 1028 1300 THE AMERICAN JOURNAL OF CARDIOLOGY? VOL. 75 JUNE 15 ) 1995 SUBJECT INDEX JANUARY 1, 1995 THROUGH JUNE 15, 1995 1231 Metaiodobenzylguanidine (MIBG) Effectiveness of Percuianeous Transiuminal Comparison Using Dynamic Vectorcardiography Regional Myocardial Sympathetic Dysinnervation Coronary Angioplasty for Patients with and MIBI SPECT of ST-Segment Changes and in Patients with Coronary Vasospasm; 324 Medically Refractory Rest Angina Pectoris and Myocardial MIBI Uptake During Percutaneous High Risk of Adverse Outcomes with Coronary Transluminal Coronary Angioplasty of the Left 5-Fluorouracil Artery Bypass Grafting; 237 Anterior Descending Coronary Artery; 998 5-Fluorouracil Cardiotoxicity with Left Ventricular Dysfunction Under Different Dosing Regimens; Effects of Previous Angina Pectoris in Patients Directional Atherectomy of Coronary and Saphe- 194 With First Acute Myocardial Infarction Not nous Vein Graft Ostial Stenoses; 1015 Receiving Thrombolytics; 615 Effect of Platelet Glycoprotein IIb/Illa Integrin Acetylcholine Enalapril-Induced Regression of Hypertensive Blockade on Activated Clotting Time During Effects of Short-Term Brachial Arterial Vasodila- Left Ventricular Hypertrophy, Regional Ische- Percutaneous Transluminal Coronary Angio- tor Infusions on Forearm Blood Flow Response mia, and Microvascular Angina; 850 plasty or Directional Atherectomy (The EPIC to Acetylcholine; 546 Enhanced Vasomotor Responses of Complex Trial); 559 Enhanced Vasomotor Responses of Complex Coronary Stenoses to Acetylcholine in Stable Effectiveness of Percutaneous Transluminal Coronary Stenoses to Acetylcholine in Stable Angina Pectoris; 725 Coronary Angioplasty for Patients with Med- Angina Pectoris; 725 Long-Term Outcome of Octogenarians with ically Refractory Rest Angina Pectoris and Increased Susceptibility of Angiographically Unstable Angina Treated Conservatively; 174 High Risk of Adverse Outcomes with Coronary Smooth Left Anterior Descending Coronary Artery Bypass Grafting; 237 Microvascular Angina Pectoris in Hypertensive Artery to an Impairment of Vasoresponse to Patients with Left Ventricular Hypertrophy and Effects of Chronic Warfarin Therapy on Compli- Acetylcholine, and the Relation Between Diagnostic Value of Exercise Thallium-201 cations of Coronary Angioplasty During Acute Impaired Vasoresponse and Low-Density Scintigraphy; 335 Myocardial Infarction; 724 Lipoprotein Cholestero! Level; 1265 Placebo-Controlled Evaluation of Three Doses oi Impact of Coronary Angioplasty on Coronary Acromegaly a Controlled-Onset, Extended-Release Formula- Vasodilator Response of Normal Nondilated Cardiopulmonary Performance During Exercise tion of Verapamil in the Treatment of Stable Coronary Arteries in Patients With Stable in Acromegaly, and the Effects of Acute Sup- Angina Pectoris; 1102 Angina; 1070 pression of Growth Hormone Hypersecretion With Octreotide; 1042 Predictors of Non—Q-Wave Acute Myocardial Intracoronary Stenting in the Treatment of Acute Infarction in Patients With Acute Ischemic or Threatened Closure in Angiographically Adenosine Syndromes: An Analysis from the Throm- Small Coronary Arteries (<3.0 mm) Complicat- Adenosine Therapy for Supraventricular Tachy- bolysis in Myocardia! Ischemia (TIMI) III ing Percutaneous Transluminal Coronary cardia During Pregnancy; 521 Trials; 977 Angioplasty; 23 Use of Adenosine-Sensitive Nondecremental Relation Between Myocardial Infarction Site and One-Stage Coronary Angiography and Angio- Accessory Pathways in Assessing the Results Pain Location in Q-Wave Acute Myocardial plasty; 30 of Radiofrequency Catheter Ablation; 1278 Infarction; 224 Predictors of Groin Complications After Balloon Use of Transesophageal Atrial Pacing with Three-Month Efficacy and Safety of Once-Daily and New-Device Coronary Intervention; 886 APrdeeenxocsiitantei onI;n fu5s4i8o n to Evaluate Ventricular Diltiazem in Chronic Stable Angina Pectoris; Predictors of Restenosis After Excimer Laser 555 Coronary Angioplasty; 1012 Usefulness of Adenosine in Diagnosis of Tachy- arrhythmias; 952 Three-Year Sustained Benefit from Enhanced Primary Coronary Angioplasty for Acute Myocar- External Counterpulsation in Chronic Angina dial Infarction Complicated by Out-of-Hospital Alexithymia Pectoris; 840 Cardiac Arrest; 1069 Psychosocial Factors Related to Unrecognized Acute Myocardial Infarction; 1211 Angiography ' Quantitative Assessment of Coronary Arterial Comparison of Quantitative Angiographically Diameter Before and After Balloon Angioplasty Ambulatory Monitoring Derived and Measured Translesion Pressure of Severe Stenoses; 939 Relation Between Diurnal Variation of Blood and Flow Velocity in Coronary Artery Disease; Single-Stage Coronary Angiography and Angio- Pressure and Left Ventricular Mass in a 111 plasty: A New Standard?; 75 Chinese Population; 1239 Long-Term Reproducibility of Coronary Flow Utility of Various Clinical, Noninvasive, and Inva- Amiodarone Velocity Measurements in Patients With sive Procedures for Determining the Causes of Acute Electrophysiologic Effects of Amiodarone Coronary Artery Disease; 1177 Recurrence of Myocardial Ischemia or Infarc- in Patients With Congestive Heart Failure; 1158 One-Stage Coronary Angiography and tion >1 Year After Percutaneous Transluminal Divergent Effects of Chronic Amiodarone Angioplasty; 30 Coronary Angioplasty; 1003 Administration on Systolic and Diastolic Function in Patients with Heart Disease; 465 Single-Stage Coronary Angiography and Angioscopy Intravenous Flecainide Versus Amiodarone for Angioplasty: A New Standard?; 75 Angioscopic Versus Angiographic Detection of Recent-Onset Atrial Fibrillation; 693 Thrombus During Coronary Interventional Pro- Angioplasty cedures; 1083 Anastomosis Angioscopic Versus Angiographic Detection of Coronary Stenting with Angioscopic Guidance; Factors Influencing Survival in Patients Undergo- Thrombus During Coronary Interventional 344 ing the Bidirectional Glenn Anastomosis; 1048 Procedures; 1083 Angina Balloon Angioplasty Versus Rotational Angio- Angiotensin-Converting Enzyme (ACE) A New Clinical Classification for Hospital plasty in Chronic Coronary Occlusions (the Inhibitor Prognosis of Unstable Angina Pectoris; 993 BAROCCO Study); 330 Angiotensin-Converting Enzyme Inhibitor Use in Survivors of Acute Myocardial Infarction; 1184 Comparison of Coronary Lesions Obtained By Comparison of in-Hospital Outcome in Men Directional Coronary Atherectomy in Unstable Versus Women Treated by Either Thrombolytic Effect of Long-Term Enalapril Therapy on Angina, Stable Angina, and Restenosis After Therapy or Primary Coronary Angioplasty for Neurohormones in Patients With Left Either Atherectomy or Angioplasty; 675 Acute Myocardial Infarction; 987 Ventricular Dysfunction; 1151 SUBJECT INDEX 1301 Effects of Fosinopril on Exercise Tolerance and Arm Exercise Reproducibility of the Measurement of Coronary Clinical Deterioration in Patients with Chronic Symptom-Limited Arm Exercise Increases Calcium With Ultrafast Computed Tomography; Congestive Heart Failure Not Taking Digitalis; Detection of Ischemia During Dipyridamole 973 596 Tomographic Thallium Stress Testing in Athlete’s Heart Racial Difference in Incidence of Cough With Patients With Coronary Artery Disease; 568 Preparticipation Cardiovascular Evaluation of the Angiotensin-Converting Enzyme Inhibitors Arrhythmia Competitive Athlete: Perspectives from the 30- (A Tale of Two Cities); 967 Calculation of QTc Duration and Variability in the Year Italian Experience; 827 When a Question Has an Answer: Rationale for Presence of Sinus Arrhythmia; 950 Our Early Termination of the HEART Trial; 1173 Divergent Effects of Chronic Amiodarone AAtrrrihaylt hmFiiabsr ilAfltaetri oCna rdioverter-Defibrillator Anteroapical Infarct Administration on Systolic and Diastolic Implantation: Comparison of Epicardial and Does the Electrocardiographic Pattern of Function in Patients with Heart Disease; 465 Transvenous Systems; 137 “Anteroseptal” Myocardial Infarction Correlate Effect of Propranolol on Circadian Variation of Correlation of Atrial Fibrillation, Paroxysmal With the Anatomic Location of Myocardial Ventricular Arrhythmias in Elderly Patients with Supraventricular Tachycardia, and Sinus Injury?; 763 Heart Disease and Complex Ventricular Rhythm with incidences of New Coronary Anteroseptal Infarct Arrhythmias; 514 Events in 1,359 Patients, Mean Age 81 Years, Does the Electrocardiographic Pattern of Effects of Obesity on QT, RR, and QTc Intervals; with Heart Disease; 182 “Anteroseptal” Myocardial Infarction Correlate 956 Efficacy and Safety of Digoxin Alone and in With the Anatomic Location of Myocardial Lack of Long-Term Ventricular Arrhythmia Combination with Low-Dose Diltiazem or Injury?; 763 Reduction by Enalapril in Heart Failure; 1244 Betaxolol to Control Ventricular Rate in Chron- Antiarrhythmics Peripheral Thyroid Hormone Metabolism in ic Atrial Fibrillation; 88 Acute Electrophysiologic Effects of Amiodarone Patients With Complex Ventricular Hemodynamic Effects of Oral Propafenone Dur- in Patients With Congestive Heart Failure; 1158 Arrhythmias; 630 ing Both Sinus Rhythm and Atrial Fibrillation; Antiarrhythmics Versus Implantable Defibrillators Signal-Averaged Electrocardiography in Familial 91 (AVID)—Rationale, Design, and Methods; 470 Form of Arrhythmogenic Right Ventricular Car- Intravenous Flecainide Versus Amiodarone for diomyopathy; 1038 Recent-Onset Atrial Fibrillation; 693 Antioxidants Effect of Combined 17B-Estradiol and Vitamin E Arteriography Relation of Left Atrial Appendage Function to the on Low-Density Lipoprotein Oxidation in Post- Correlation of Coronary Stenosis by Quantitative Duration and Reversibility of Nonvalvular Atrial menopausal Women; 1274 Coronary Arteriography with Exercise Echo- Fibrillation; 944 cardiography; 287 Safety and Efficacy of Intravenous Diltiazem in Anxiety Disorder Atria! Fibrillation or Atrial Flutter; 45 Decreased Heart Rate Variability in Men With Artificial Neural Networks Phobic Anxiety (Data from the Normative Artificial Neural Networks for Recognition of Temporal Dependence of the Return of Atrial Aging Study); 882 Electrocardiographic Lead Reversal; 929 Mechanical Function on the Mode of Car- dioversion of Atrial Fibrillation to Sinus Aortic Arch Aspirin Rhythm; 624 Single-Stage Repair of Aortic Arch Obstruction Design of a Placebo-Controlled Clinical Tria! The Best Criterion for Discrimination Between and Associated Intracardiac Defects in the of Long-Acting Diltiazem and Aspirin Versus Patients With and Without Paroxysmal Atrial Neonate; 370 Aspirin Alone in Patients Receiving Throm- bolysis With a First Acute Myocardial Fibrillation on Signal-Averaged Electrocardio- Aortic Dissection Infarction; 1120 gram; 93 Usefulness of a Prototype Intravascular Effect of Aspirin on Spontaneous Contrast in the Atrial Flutter Ultrasound Imaging in Evaluation of Aortic Brachial Veins of Normal Subjects; 924 Does Complexity Theory Apply to the Conduction Dissection and Comparison with Angiographic Ratios Occurring During Progression of Stable Study, Transesophageal Echocardiography, Asystole Atrial Flutter With 2:1 Into 4:1 Atrioventricular Computed Tomography, and Magnetic Reso- Relevance of Asystole During Head-Up Tilt Block?; 947 nance Imaging; 161 Testing; 251 Atrial Natriuretic Peptide Aortic Regurgitation Atherectomy Effect of Long-Term Enalapril Therapy on Neuro- Prevalence of Cardiac Manifestations of Juvenile Comparison of Coronary Lesions Obtained By hormones in Patients With Left Ventricular Ankylosing Spondylitis; 744 Directional Coronary Atherectomy in Unstable Dysfunction; 1151 Angina, Stable Angina, and Restenosis After Aortic Root Dimension Either Atherectomy or Angioplasty; 675 Improvement in Exercise-Induced Left Echocardiographic Assessment of Aortic Root Ventricular Dysfunction by Infusion of Dimensions in Normal Children Based on Directional Atherectomy of Coronary and Measurement of a New Ratio of Aortic Size Saphenous Vein Graft Ostial Stenoses; 1015 a-Human Atrial Natriuretic Peptide in Coronary Artery Disease; 449 Independent of Growth; 711 Quantitative Assessment With Intracoronary Aortic Stenosis Uitrasound of the Mechanisms of Restenosis Atrial Septal Aneurysm Prevalence of Extracranial Carotid Arterial After Percutaneous Transluminal Balloon Absence of Cerebrovascular Events in a Prospec- Disease and of Valvular Aortic Stenosis and Angioplasty and Directional Coronary tive Study of Coronary Artery Bypass Patients Their Association in the Elderly; 304 Atherectomy; 772 with Atrial Septal Aneurysms Taking Aspirin; 305 Progression of Asymptomatic Aortic Stenosis Atherosclerosis Identified in the Neonatal Period; 636 Evidence That Homocysteine Is an Independent Atrial Septal Defect Usefulness of Dobutamine Echocardiography in Risk Factor for Atherosclerosis in Hyperlipi- Quantitation of Left-to-Right Shunts in Secun- Distinguishing Severe from Nonsevere Valvular demic Patients; 132 dum Atrial Septal Defect by Two-Dimensional Aortic Stenosis in Patients with Depressed Left High-Density Lipoprotein Subfractions as Contrast Echocardiography With Use of Ventricular Function and Low Transvalvular Markers of Early Atherosclerosis; 127 Albunex; 639 Gradients; 191 Pravastatin, Lipids, and Atherosclerosis in the Atrial Volume Aortic Thrombus Carotid Arteries (PLAC-II); 455 Comparison of Left Atrial Volume by Two- A Rare Case of Coronary Artery Occlusion Racia! Differences in Coronary Calcium Dimensional Echocardiography and Cine-Com- Diagnosed by Echocardiography; 104 Prevalence Among High-Risk Adults; 1088 puted Tomography; 754 1302 THE AMERICAN JOURNAL OF CARDIOLOGY® VOL 75: JUNE 1S 1995 Atrioventricular Block Cardiac Rehabilitation Gender Differences in the Utilization of Cardiac Prognostic Significance of Transient Complete Comparison of Outcome of Cardiac Rehabilita- Catheterization for the Diagnosis of Chest Atrioventricular Block During Radiofrequency tion in Black Women and White Women; 890 Pain; 79 Ablation of Atrioventricular Node Reentrant Effects of Cardiac Rehabilitation and Exercise Initial Experience With Percutaneous Tachycardia; 698 Training on Exercise Capacity, Coronary Risk Transhepatic Cardiac Catheterization in Autonomic Nervous Function Factors, Behavioral Characteristics, and Quality Infants and Children; 1289 Heart Rate Variability During Repeated Arterial of Life in Women; 340 Natural History and Management Strategies of Occlusion in Coronary Angioplasty; 877 Norepinephrine and Atrial Natriuretic Peptide Automatic Atrial Tachycardia in Children; 405 Responses to Exercise Testing in Rehabilitated BSyesStttaoil miucAl daatrnieodnn oDicianes tpNootlriocmr aslE ffHecutmsa nosf; B-2A0d6r energic aACncadurt deiN oonMmryyeoohcpaaabrtidlhiiyat la tAefIdtne fra MrceHtenia olniW;ni gt1 h0 o7fI2 s Acnhteemriiocr Wall PrAeCcadruidtsiepa ocsN ienCugar tohlReotigesirkci z FaaCtcoitomonpr;ls i c1aa0nt5di6 o nNsa tuorfa lL eHfits-tSoirdye d of Prognostic Significance of Transient Complete Beta Blockers Cardiomyopathy Atrioventricular Block During Radiofrequency Design of the Beta-Blocker Evaluation Survival Design of the Beta-Blocker Evaluation Survival Ablation of Atrioventricular Node Reentrant Trial (BEST); 1220 Trial (BEST); 1220 Tachycardia; 698 Dipyridamole Echocardiography for Diagnosis of Effect of Doxazosin or Atenolol on Exercise Coexistent Coronary Artery Disease in Hyper- Radiofrequency Catheter Ablation for Control of Performance in Physically Active, Hypertensive trophic Cardiomyopathy; 810 Frequent Ventricular Tachycardia with Healed Men; 258 Myocardial Infarction; 297 Major Cardiac Findings at Necropsy in 366 Effects of Atenoiol on Rest and Exercise Hemo- American Octogenarians; 151 The Learning Curve for Radiofrequency Ablation dynamics in Patients with Mitral Stenosis; 482 of Tachyarrhythmias in Pediatric Patients; 587 Measuring Extracellular Matrix Turnover in the Hemodynamic and Energetic Comparison of Serum of Patients With Idiopathic or Ischemic Two-Dimensional and Doppler Ultrasound Bucindolol and Metoprolo! for the Treatment of Dilated Cardiomyopathy and Impact on Evaluation of Femoral Arteries in Infants After Congestive Heart Failure; 360 Diagnosis and Prognosis; 913 Cardiac Catheterization; 642 Biphasic Waveforms Norepinephrine and Atrial Natriuretic Peptide Use of Adenosine-Sensitive Nondecremental Comparison of Monophasic and Biphasic Responses to Exercise Testing in Rehabilitated Accessory Pathways in Assessing the Results Defibrillating Pulse Waveforms for and Nonrehabilitated Men With Ischemic of Radiofrequency Catheter Ablation; 1278 Transthoracic Cardioversion; 1135 Cardiomyopathy After Healing of Anterior Wall Usefulness of Follow-Up Electrophysiologic Acute Myocardial Infarction; 1072 Blood Pressure Study and Event Monitoring After Successful Relation of Left Ventricular Mass and Filling to Prognostic Significance of Spectral Turbulence Radiofrequency Catheter Ablation of Supraven- Exercise Blood Pressure and to Rest Blood Analysis of the Signal-Averaged Electrocardio- tricular Tachycardia; 50 Pressure; 53 gram in Patients With Idiopathic Dilated Cardiomyopathy; 494 Cerebrovascular Disease Bundle Branch Block Prognostic Value of the Signal-Averaged Electro- Safety of Dipyridamole Testing in Patients with Transient Loss of Complete Bundle Branch Block cardiogram and a Prolonged QRS in Ischemic Cerebrovascular Disease; 535 Patterns During Exercise; 523 and Nonischemic Cardiomyopathy; 460 Chromosome 22 Carcinoid Heart Disease Provocation of Latent Left Ventricular Outflow Transposition of the Great Arteries Associated Tract Gradients With Amyl Nitrite and Exercise Predictors of Outcome of Tricuspid Valve with Deletion of Chromosome 22q11; 95 in Hypertrophic Cardiomyopathy; 805 Replacement in Carcinoid Heart Disease; 485 Reversal of Primary Hyperoxaluria Cardio- Cholestyramine Calcium Channel Blocker myopathy After Combined Liver and Renal Effects of Variable Doses and Formulations of Safety and Efficacy of intravenous Diltiazem in Transplantation; 210 Cholestyramine on Elevated Serum Low- Atrial Fibrillation or Atrial Flutter; 45 Signal-Averaged Electrocardiography in Familial Density Lipoprotein Cholesterol; 738 Calcium Sensitizers Form of Arrhythmogenic Right Ventricular Cigarette Smoking Hemodynamic and Neurohumoral Effects of Lev- Cardiomyopathy; 1038 Exercise Training and Reduction of Some osimendan, a New Calcium Sensitizer, at Rest Cardiotoxicity Coronary Risk Factors in Female Cigarette and During Exercise in Healthy Men; 1061 5-Fluorouracil Cardiotoxicity with Left Ventricular Smokers; 85 Cancer Dysfunction Under Different Dosing Regimens; Circadian Rhythm Orthotopic Heart Transplantation in Patients With 194 Circadian Variation of Ischemic Threshold ini Treated Malignancies; 968 Erythromycin-induced Carcliac Toxicity; 859 Syndrome X; 683 Cardiac Arrest Functional Cardiac Disturbances Related to Circadian Variation of Ventricular Arrhythmia Primary Coronary Angioplasty for Acute Chemotherapy Independent of Anthracycline Recurrences After Cardioverter-Defibrillator Myocardial Infarction Complicated by Out-of- Use in Children with Neoplastic Disease; 101 Implantation in Patients With Healed Hospital Cardiac Arrest; 1069 Carotid Arteries Myocardial Infarcts; 1140 Usefulness of an Abnormal Signal-Averaged Pravastatin, Lipids, and Atherosclerosis in the Effect of Propranolol on Circadian Variation of Electrocardiogram for Predicting Cardiac Carotid Arteries (PLAC-II); 455 Ventricular Arrhythmias in Elderly Patients Death in Elderly Persons Without Heart Prevalence of Extracranial Carotid Arterial with Heart Disease and Complex Ventricular Disease; 1273 Disease and of Valvular Aortic Stenosis and Arrhythmias; 514 Their Association in the Elderly; 304 Cardiac Output Coarctation Cardiac Output in Single-Lead VDD Pacing Carotid Sinus Syndrome Exercise-induced Hypertension in the Arms Due Versus Rate-Matched VVIR Pacing; 904 Reappraisal of the Vasodepressor Reflex in to Impaired Arterial Reactivity After Successful Quantitation of Cardiac Output With Velocity- Carotid Sinus Syndrome; 518 Coarctation Resection; 814 Encoded, Phase-Difference Magnetic Catheterization Location of the Left Papillary Muscles in Resonance Imaging; 1250 Effect of Residual Slow Pathway Function on the Juxtaductal Aortic Coarctation; 746 Results of Atrioventricular Synchronous Pacing Time Course of Recurrences of Atrioventricular Single-Stage Repair of Aortic Arch Obstruction With Optimized Delay in Patients With Severe Nodal Reentrant Tachycardia After Radiofre- and Associated Intracardiac Defects in the Congestive Heart Failure; 919 quency Ablation of the Slow Pathway; 628 Neonate; 370 SUBJECT INDEX 1303 Cocaine Coronary Artery Anomalies Energy Expenditure During Household Tasks in Myocardial Perfusion Pattern in Patients with Differentiating Anomalous Left Main Coronary Women With Coronary Artery Disease; 670 Cocaine-Induced Chest Pain; 396 Artery Originating from the Pulmonary Trunk Failure of Cholesterol Treatment in Patients with in Infants from Myocarditis and Dilated Coronary Artery Disease: A Cost-Effective Cold Pressor Test Cardiomyopathy by Electrocardiogram; 71 Solution; 277 Correlation of Cold Pressor and Flow-Mediated Brachial Artery Diameter Responses With the Woven Left Coronary Artery Disease; 311 Homocysteine and Coronary Artery Disease in Presence of Coronary Artery Disease; 783 Coronary Artery Bypass Grafting French Canadian Subjects: Relation With Vitamins By, Bg, Pyridoxal Phosphate, and Colestipol (CABG) Folate; 1107 Enhanced Low-Density Lipoprotein Cholesterol Coronary Risk Factors in Women Six Months Reduction and Cost-Effectiveness by Low-Dose After Coronary Artery Bypass Grafting; 1092 Intravascular Ultrasound Assessment of the Colestipol Plus Lovastatin Combination Effectiveness of Percutaneous Transiuminal Magnitude and Mechanism of Coronary Artery Therapy; 34 Coronary Angioplasty for Patients with Med- and Lumen Tapering; 177 Commissurotomy ically Refractory Rest Angina Pectoris and Limitations of Estimating Metabolic Equivalents Cerebral Microembolism Detected By Trans- High Risk of Adverse Outcomes with Coronary in Exercise Assessment in Patients With Coro- cranial Doppler During Percutaneous Trans- Artery Bypass Grafting; 237 nary Artery Disease; 940 venous Mitral Commissurotomy; 189 Gaseous Coronary Embolism as a Cause of Myo- Long-Term Prognosis of Patients With a Normal Percutaneous Mitral Balloon Valvotomy for cardial Ischemia During Coronary Artery Exercise Echocardiogram and Clinical Suspi- Recurrent Mitral Stenosis After Surgical Bypass Grafting; 282 cion of Myocardial Ischemia; 934 Commissurotomy; 601 Importance of the Internal Mammary Artery for Long-Term Prognostic Value of Exercise Testing Safety of Inoue Balloon Mitral Commissurotomy Coronary Bypass Grafting in Patients Aged >70 in Men and Women from the Coronary Artery in Patients with Left Atrial Appendage Throm- Years; 734 Surgery Study (CASS) Registry; 865 bi; 302 Monomorphic Versus Polymorphic Ventricular Major Cardiac Findings at Necropsy in 366 Tachycardia After Coronary Artery Bypass American Octogenarians; 151 Complexity Does Complexity Theory Apply to the Conduction Grafting; 403 Myocardial Ischemia During Sexual Activity in Ratios Occurring During Progression of Stable Noninvasive Evaluation of Aortocoronary Bypass Patients With Coronary Artery Disease; 835 Atrial Flutter With 2:1 Into 4:1 Atrioventricular Grafts With Magnetic Resonance Flow Map- Quantitative Assessment of Coronary Arterial Block?; 947 ping; 845 Diameter Before and After Balloon Angioplasty of Severe Stenoses; 939 Congenital Heart Disease Coronary Artery Disease Acquired Coronary Artery Fistulae After Right Apolipoprotein €4 is not a Genetic Risk Factor Regional Heterogeneity on Myocardial Contrast Ventricular Myotomy and/or Myomectomy for for Coronary Artery Disease or Restenosis Echocardiography Without Severe Obstructive Congenital Heart Disease; 408 After Percutaneous Transluminal Coronary Coronary Artery Disease; $82 Comparison Between Cine Magnetic Resonance Angioplasty; 1181 Relation of Angiographically Defined Coronary Velocity Mapping and First-Pass Radionuclide Attitudes of Attending Physicians to the Inciden- Artery Disease and Plasma Concentrations of Angiocardiography for Quantitating Intracardiac tal Diagnosis of Hypercholesterolemia in Hos- Insulin, Lipid, and Apolipoprotein in Normolipi- Shunts; 529 pitalized Patients; 511 demic Subjects with Varying Degrees of Glu- Factors Influencing Survival in Patients Undergo- Baseline Characteristics in the Cholesterol and cose Tolerance; 122 ing the Bidirectional Glenn Anastomosis; 1048 Recurrent Events (CARE) Trial of Secondary Usefulness of Dobutamine Stress Echocardiog- Initial Experience With Percutaneous Prevention in Patients With Average Serum raphy in: Detecting Coronary Artery Disease in Transhepatic Cardiac Catheterization in Cholesterol Levels; 621 End-Stage Renal Disease; 707 Infants and Children; 1289 Comparison of Frequency of Magnesium Defi- Usefulness of U-Wave Analysis in Detecting Sig- Prevalence, Relation to Spontaneous Closure, ciency in Patients With Vasospastic Angina nificant Narrowing Limited to a Single Coro- and Association of Muscular Ventricular Septal and Fixed Coronary Artery Disease; 728 nary Artery; 508 Defects with Other Cardiac Malformations; 61 Comparison of Rest-Redistribution Thallium-201 Coronary Calcium Pulmonary and Systemic Venous Flow Patterns Imaging and Reinjection After Stress-Redistrib- Racial Differences in Coronary Calcium Preva- Assessed by Transesophageal Doppler ution for the Assessment of Myocardial Viabili- lence Among High-Risk Adults; 1088 Echocardiography in Congenital Absence ty in Patients with Left Ventricular Dysfunction of the Pericardium; 1286 Secondary to Coronary Artery Disease; 436 Coronary Flow Reserve Comparison of Quantitative Angiographically Role of Late Potentials in Identifying Patients at Correlation of Cold Pressor and Flow-Mediated Derived and Measured Translesion Pressure Risk for Ventricular Tachycardia After Surgical Brachial Artery Diameter Responses With the and Flow Velocity in Coronary Artery Disease; Correction of Congenital Heart Disease; 146 Presence of Coronary Artery Disease; 783 111 Single-Stage Repair of Aortic Arch Obstruction Decreased Heart Rate Variability in Men With and Associated Intracardiac Defects in the Phobic Anxiety (Data from the Normative The Physiologic Meaning of Relative Coronary Neonate; 370 Aging Study); 882 Flow Reserve; 285 Congestive Heart Failure Diagnostic Accuracy of Heart Rate—Adjusted ST Coronary Occlusion Acute Electrophysiologic Effects of Amiodarone Segments Compared with Standard ST-Seg- Balloon Angioplasty Versus Rotational Angio- in Patients With Congestive Heart Failure; 1158 ment Criteria; 118 plasty in Chronic Coronary Occlusions (the BAROCCO Study); 330 Compartmental Analysis of Norepinephrine Dipyridamole Echocardiography for Diagnosis of Kinetics in Congestive Heart Failure; 299 Coexistent Coronary Artery Disease in Hyper- Coronary Ostium Early Versus Late Congestive Heart Failure After trophic Cardiomyopathy; 810 Directional Atherectomy of Coronary and Saphe- Initially Uncomplicated Anterior Wall Acute Distribution of Lipids in 8,500 Men With Coro- nous Vein Graft Ostial Stenoses; 1015 Myocardial Infarction; 653 nary Artery Disease; 1196 Cost-effectiveness Neurohumoral Variability in Left Ventricular Divergent Reporting of Coronary Risk Factors A Cost-Effectiveness Strategy for Transtelephon- Dysfunction; 354 Before Coronary Artery Bypass Surgery; 736 ic Arrhythmia Monitoring; 184 Noninvasive Estimation of Pulmonary Arterial Does Preoperative Coronary Revascularization Enhanced Low-Density Lipoprotein Cholesterol Wedge Pressure with Doppler Transmitral Flow Before Noncardiac Surgery Reduce the Risk of Reduction and Cost-Effectiveness by Low- Velocity Pattern in Patients with Known Heart Coronary Events in Patients With Known Coro- Dose Colestipol Plus Lovastatin Combination Disease; 383 nary Artery Disease?; 829 Therapy; 34 1304 THE AMERICAN JOURNAL OF CARDIOLOGY® VOL. 75 JUNE 15, 1995